Attached files

file filename
EX-32.1 - EX-32.1 - BICYCLE THERAPEUTICS plcbcyc-20201231ex321aa90a9.htm
EX-31.2 - EX-31.2 - BICYCLE THERAPEUTICS plcbcyc-20201231ex3129532f3.htm
EX-31.1 - EX-31.1 - BICYCLE THERAPEUTICS plcbcyc-20201231ex3118f1a38.htm
EX-10.28 - EX-10.28 - BICYCLE THERAPEUTICS plcbcyc-20201231ex102866327.htm
EX-10.27 - EX-10.27 - BICYCLE THERAPEUTICS plcbcyc-20201231ex102755560.htm
EX-10.24 - EX-10.24 - BICYCLE THERAPEUTICS plcbcyc-20201231ex1024a9f8a.htm
EX-10.23 - EX-10.23 - BICYCLE THERAPEUTICS plcbcyc-20201231ex102314767.htm
EX-10.18 - EX-10.18 - BICYCLE THERAPEUTICS plcbcyc-20201231ex1018629e2.htm
EX-10.14 - EX-10.14 - BICYCLE THERAPEUTICS plcbcyc-20201231ex1014e249f.htm
EX-4.4 - EX-4.4 - BICYCLE THERAPEUTICS plcbcyc-20201231ex446072044.htm
10-K - 10-K - BICYCLE THERAPEUTICS plcbcyc-20201231x10k.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-231718, 333-237054, 333-240993) and Form S-3 (No. 333-238996) of Bicycle Therapeutics plc of our report dated March 11, 2021 relating to the financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Cambridge, United Kingdom

March 11, 2021